149 related articles for article (PubMed ID: 28643328)
21. How good are publicly available web services that predict bioactivity profiles for drug repurposing?
Murtazalieva KA; Druzhilovskiy DS; Goel RK; Sastry GN; Poroikov VV
SAR QSAR Environ Res; 2017 Oct; 28(10):843-862. PubMed ID: 29183230
[TBL] [Abstract][Full Text] [Related]
22. BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis.
Irrera N; Vaccaro M; Bitto A; Pallio G; Pizzino G; Lentini M; Arcoraci V; Minutoli L; Scuruchi M; Cutroneo G; Anastasi GP; Ettari R; Squadrito F; Altavilla D
Clin Sci (Lond); 2017 Mar; 131(6):487-498. PubMed ID: 28096316
[TBL] [Abstract][Full Text] [Related]
23. Next-generation drug repurposing using human genetics and network biology.
Nabirotchkin S; Peluffo AE; Rinaudo P; Yu J; Hajj R; Cohen D
Curr Opin Pharmacol; 2020 Apr; 51():78-92. PubMed ID: 31982325
[TBL] [Abstract][Full Text] [Related]
24. A Machine-Learning-Based Drug Repurposing Approach Using Baseline Regularization.
Kuang Z; Bao Y; Thomson J; Caldwell M; Peissig P; Stewart R; Willett R; Page D
Methods Mol Biol; 2019; 1903():255-267. PubMed ID: 30547447
[TBL] [Abstract][Full Text] [Related]
25. Network-based Drug Repurposing: A Critical Review.
Selvaraj N; Swaroop AK; Nidamanuri BSS; Kumar RR; Natarajan J; Selvaraj J
Curr Drug Res Rev; 2022; 14(2):116-131. PubMed ID: 35156575
[TBL] [Abstract][Full Text] [Related]
26. NF-κB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH.
Andrés RM; Montesinos MC; Navalón P; Payá M; Terencio MC
J Invest Dermatol; 2013 Oct; 133(10):2362-2371. PubMed ID: 23594598
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic and immunomodulatory effects of glucosamine in combination with low-dose cyclosporine a in a murine model of imiquimod-induced psoriasis.
Kim CH; Kim JY; Lee AY
Eur J Pharmacol; 2015 Jun; 756():43-51. PubMed ID: 25796200
[TBL] [Abstract][Full Text] [Related]
28. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
29. A novel integrated action crossing method for drug-drug interaction prediction in non-communicable diseases.
Hunta S; Yooyativong T; Aunsri N
Comput Methods Programs Biomed; 2018 Sep; 163():183-193. PubMed ID: 30119852
[TBL] [Abstract][Full Text] [Related]
30. Structure-based drug designing and identification of Woodfordia fruticosa inhibitors targeted against heat shock protein (HSP70-1) as suppressor for Imiquimod-induced psoriasis like skin inflammation in mice model.
Raghuwanshi N; Yadav TC; Srivastava AK; Raj U; Varadwaj P; Pruthi V
Mater Sci Eng C Mater Biol Appl; 2019 Feb; 95():57-71. PubMed ID: 30573271
[TBL] [Abstract][Full Text] [Related]
31. Gold lotion from citrus peel extract ameliorates imiquimod-induced psoriasis-like dermatitis in murine.
Lin CC; Wu JJ; Pan YG; Chao YH; Lin FC; Lee YR; Chu CL
J Sci Food Agric; 2018 Nov; 98(14):5509-5517. PubMed ID: 29691866
[TBL] [Abstract][Full Text] [Related]
32. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
Morimura S; Oka T; Sugaya M; Sato S
J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
[TBL] [Abstract][Full Text] [Related]
33. Topically applied azaphenothiazines inhibit experimental psoriasis in mice.
Artym J; Kocięba M; Zaczyńska E; Kochanowska I; Zimecki M; Kałas W; Fiedorowicz A; Pawlak A; Strządała L; Jeleń M; Morak-Młodawska B; Pluta K; Kaleta-Kuratewicz K; Madej JP; Kuropka P; Kuryszko J
Int Immunopharmacol; 2018 Jun; 59():276-286. PubMed ID: 29674255
[TBL] [Abstract][Full Text] [Related]
34. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of imiquimod-induced psoriasis-like dermatitis in mice by herbal extracts from some Indian medicinal plants.
Arora N; Shah K; Pandey-Rai S
Protoplasma; 2016 Mar; 253(2):503-15. PubMed ID: 26016607
[TBL] [Abstract][Full Text] [Related]
36. Discovery of Surface Target Proteins Linking Drugs, Molecular Markers, Gene Regulation, Protein Networks, and Disease by Using a Web-Based Platform Targets-search.
Yan B; Wang P; Wang J; Boheler KR
Methods Mol Biol; 2018; 1722():331-344. PubMed ID: 29264813
[TBL] [Abstract][Full Text] [Related]
37. Aromatic-turmerone ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c mice.
Li YL; Du ZY; Li PH; Yan L; Zhou W; Tang YD; Liu GR; Fang YX; Zhang K; Dong CZ; Chen HX
Int Immunopharmacol; 2018 Nov; 64():319-325. PubMed ID: 30243067
[TBL] [Abstract][Full Text] [Related]
38. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway.
Chen H; Lu C; Liu H; Wang M; Zhao H; Yan Y; Han L
Int Immunopharmacol; 2017 Jul; 48():110-117. PubMed ID: 28499194
[TBL] [Abstract][Full Text] [Related]
39. Functional Module Connectivity Map (FMCM): a framework for searching repurposed drug compounds for systems treatment of cancer and an application to colorectal adenocarcinoma.
Chung FH; Chiang YR; Tseng AL; Sung YC; Lu J; Huang MC; Ma N; Lee HC
PLoS One; 2014; 9(1):e86299. PubMed ID: 24475102
[TBL] [Abstract][Full Text] [Related]
40. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model.
Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC
Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
